Advertisement
Screener

Myomo, Inc. (MYO) Overview

Myomo, Inc. (MYO) Overview

  • 1 Apr 2026: Period ending 30 Jun 2026; Estimate (m); Actual -0.09; Beat / miss (m).
  • 1 Jan 2026: Period ending 31 Mar 2026; Estimate (m); Actual -0.07; Beat / miss (m).
  • 1 Jul 2025: Period ending 30 Sept 2025; Estimate (m); Actual -0.09; Beat / miss (m).
  • 1 Apr 2025: Period ending 30 Jun 2025; Estimate (m); Actual -0.11; Beat / miss (m).

Stock Price Chart

View more →

Blue: Split-adjusted close · Orange: Cumulative dividend-reinvested close

$0.61$0.77$0.97$1.22$1.55$1.952025-09-292026-09-29$0.38$0.79$1.64$3.41$7.08$14.702021-09-292026-09-29$0.38$1.66$7.27$31.80$139.07$608.272017-06-122026-09-29$0.38$1.66$7.27$31.80$139.07$608.272017-06-122026-09-29$0.38$1.66$7.27$31.80$139.07$608.272017-06-122026-09-29

Logarithmic scale. Both lines share the same starting value for the selected range.

Last close
$1.57
Previous close
$1.56
Change
$0.01
Change (%)
0.64%
Close date
2026-09-29
Previous close date
2026-09-28
Open
(m)
Day high
(m)
Day low
(m)
Last session volume
(m)
Last session value
(m)
Currency
USD
Price basis
split-adjusted
Volume basis
(m)

Performance

View more →

Cumulative total returns · 2026-09-29

YTD

MYO
+72.53%
S&P 500
(m)

1 year

MYO
+65.26%
S&P 500
(m)

3 years

MYO
+41.44%
S&P 500
(m)

5 years

MYO
-86.20%
S&P 500
(m)

Earnings trends

View more →

Earnings per share

USD / share · As filed

30 Jun 2026 ○ Estimate (m) ● Actual -0.09

-0.19-0.12-0.040.030.1131 Mar 2025: estimate (m); actual -0.0831 Mar 2025(m)30 Jun 2025: estimate (m); actual -0.1130 Jun 2025(m)30 Sept 2025: estimate (m); actual -0.0930 Sept 2025(m)31 Mar 2026: estimate (m); actual -0.0731 Mar 2026(m)30 Jun 2026: estimate (m); actual -0.0930 Jun 2026(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Apr 202630 Jun 2026(m)-0.09(m)(m)
1 Jan 202631 Mar 2026(m)-0.07(m)(m)
1 Jul 202530 Sept 2025(m)-0.09(m)(m)
1 Apr 202530 Jun 2025(m)-0.11(m)(m)
1 Jan 202531 Mar 2025(m)-0.08(m)(m)

31 Dec 2025 ○ Estimate (m) ● Actual -0.37

-1.97-1.47-0.97-0.480.0231 Dec 2021: estimate (m); actual -1.8931 Dec 2021(m)31 Dec 2022: estimate (m); actual -1.5231 Dec 2022(m)31 Dec 2023: estimate (m); actual -0.2831 Dec 2023(m)31 Dec 2024: estimate (m); actual -0.1631 Dec 2024(m)31 Dec 2025: estimate (m); actual -0.3731 Dec 2025(m)
Comparison details
Period startPeriod endingEstimateActualBeat / missReport date
1 Jan 202531 Dec 2025(m)-0.37(m)(m)
1 Jan 202431 Dec 2024(m)-0.16(m)(m)
1 Jan 202331 Dec 2023(m)-0.28(m)(m)
1 Jan 202231 Dec 2022(m)-1.52(m)(m)
1 Jan 202131 Dec 2021(m)-1.89(m)(m)

Revenue vs. Earnings

USD

30 Jun 2026 ■ Revenue 11.70M ■ Earnings -4.02M — Profit margin -34.36%

-6.59M-49.0%0.16M-42.2%6.91M-35.5%13.66M-28.8%30 Jun 2025: revenue 9.65M; earnings -4.63M; profit margin -47.99%30 Jun 202530 Sept 2025: revenue 10.09M; earnings -3.66M; profit margin -36.30%30 Sept 202531 Mar 2026: revenue 10.11M; earnings -3.01M; profit margin -29.76%31 Mar 202630 Jun 2026: revenue 11.70M; earnings -4.02M; profit margin -34.36%30 Jun 2026

31 Dec 2025 ■ Revenue 40.93M ■ Earnings -15.60M — Profit margin -38.12%

-22.38M-69.9%0.98M-52.6%24.35M-35.3%47.71M-18.0%31 Dec 2022: revenue 15.56M; earnings -10.72M; profit margin -68.92%31 Dec 202231 Dec 2023: revenue 19.24M; earnings -8.10M; profit margin -42.10%31 Dec 202331 Dec 2024: revenue 32.55M; earnings -6.20M; profit margin -19.05%31 Dec 202431 Dec 2025: revenue 40.93M; earnings -15.60M; profit margin -38.12%31 Dec 2025

Analyst insights

View more →
RatingsBuyHoldSellOther ratingsLast CloseAverage TargetUpsideHigh TargetLow Target
(m)(m)(m)(m)(m)$1.57(m)(m)(m)(m)
Past 12 Months12 Month ForecastLast Close$1.57High(m)Average(m)Low(m)2025-09-292026-09-29

Recent news

View more →

(m)

YouTube videos mentioning MYO

View more →

(m)

Statistics

View more →

Retained observations as of 2026-11-11; financial period ending 30 Jun 2026.

Forward P/E
(m)
PEG ratio · 5-year expected
(m)
Shares held by insiders
(m)
Insider transactions · change (%)
(m)
Shares held by institutions
(m)
Institutional transactions · change (%)
(m)
Diluted EPS · 12 month
(m)
EPS estimate · next quarter
(m)
EPS estimate · next year
(m)
EPS growth · current annual estimate
(m)
EPS growth · next annual estimate
(m)
EPS growth · next 5 years expected
(m)
EPS growth · past 3 years annualized
(m)
EPS growth · past 5 years annualized
(m)
EPS change · 12 months vs prior year
(m)
EPS change · latest quarter vs previous quarter
(m)
Latest earnings report date
(m)
EPS surprise · latest reported quarter
(m)
Net income · 12 month
$-14.53M
Profit margin
-33.59%
Return on assets · 12 month
-39.27%
Named executive and board stock awards · latest fiscal year
(m)
Index membership
(m)
Employees
194.00
IPO date
(m)
Options available
(m)
Shortable
(m)
Analyst recommendation
(m)
Analyst target price
(m)
Price volatility · week
(m)
Price volatility · month
(m)
Average true range · 14 sessions
(m)
Relative strength index · 14 sessions
(m)
Relative volume
(m)
Average daily volume
372.01K
Latest session volume
(m)
Last session value
(m)
30 days ago session value
(m)
1 year ago session value
(m)
Number of trades
(m)
Total return · week
-4.27%*
Total return · month
-1.88%*
Total return · quarter
41.44%*
Total return · half year
124.29%*
Total return · year to date
72.53%*
Total return · 1 year
65.26%*
Total return · 3 years
41.44%*
Total return · 5 years
-86.20%*
Market cap
(m)
Book value per share · latest quarter
(m)
Price / cash · latest quarter
(m)
Enterprise value
(m)
Enterprise value / revenue
(m)
Enterprise value / EBITDA
(m)
Dividend · 12 months per share
(m)
Dividend ex-date
(m)
Next dividend ex-date
(m)
Next dividend amount per share
(m)
Dividend growth · 3 years annualized
(m)
Dividend growth · 5 years annualized
(m)
Revenue · 12 month
$43.26M
Revenue growth · past 3 years annualized
(m)
Revenue growth · past 5 years annualized
(m)
Revenue change · 12 months vs prior year
(m)
Revenue change · latest quarter vs previous quarter
(m)
Revenue surprise · latest reported quarter
(m)
Levered free cash flow · 12 month
(m)
Debt / equity · latest quarter
(m)
Long-term debt / equity · latest quarter
(m)
Return on equity · 12 month
(m)
Return on invested capital · 12 months
(m)
Previous close
(m)
Latest closing price
(m)
Latest session change (%)
(m)
52-week high
(m)
52-week low
(m)
Price vs 20-session moving average
(m)
Price vs 50-session moving average
(m)
Price vs 200-session moving average
(m)
Float shares
(m)
Short float (%)
(m)
Short ratio (days to cover)
(m)
Short interest (shares)
(m)

Five-year projected P/E and P/S repeat the preceding five-year EPS and revenue CAGR, holding current price and market cap constant. Hover a calculated row for its formula. Net assets = assets − debt − payables − deferred revenue − obligations due within 1 year − obligations due after 1 year.

Holders breakdown

View more →
BreakdownOwnership
(m)Shares held by all insiders
(m)Shares held by institutions
(m)Float held by institutions
(m)Institutions holding shares

Other holders

(m)

View more →

Insider holders

(m)

View more →

Top institutional holders

(m)

View more →

Top mutual fund holders

(m)

View more →

Myomo, Inc. Overview

View more →

(m)

(m)

SEC CIK
1369290
Industry (SIC)
3842 Orthopedic, Prosthetic & Surgical Appliances & Supplies
Country of operation
United States
Business address
137 PORTLAND STREET, 4TH FLOOR, BOSTON, Massachusetts, 02114, United States
Fiscal year end
1231
Phone
617-996-9058

Similar stocks

Stock NameCountryMarket CapPE Ratio
Envoy Medical, Inc. (COCH)United States$0.056B
ALPHA PRO TECH LTD (APT)$0.052B13.63
Safe Pro Group Inc. (SPAI)United States$0.090B
MILESTONE SCIENTIFIC INC. (MLSS)United States$0.036B-6.85
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
NutriBand Inc. (NTRB)United States$0.109B
Lifeward Ltd. (LFWD)$0.021B
Conexeu Sciences Inc. (CNXU)United States$0.111B
ENvue Medical, Inc. (FEED)United States$0.011B
Bone Biologics Corp (BBLG)United States$0.001B